Pharma Sessions

Evan Reddick recently joined an exciting emerging biotech with a major phase 3 trial win, and preparing to launch a first-in-class oral medication for breast cancer, serving as the AVP and Head of Global Medical Affairs Strategy. Evan previously had a number of field and leadership roles at a large pharma. A highlight was the very first topic discussed, the framework of “Standing in Success”, and what that means for leaders. But we covered so much, I'm really excited to hear what you ha...

Riad Dirani is the VP of Global HEOR at Teva Pharmaceuticals. We talk about: Customizing data for a global audienceThe importance of a clear medical storyHow to create an insights gathering process that turns a scientific narrative into a living documentHow HEOR can best support a field teamInvolving Medical Directors in RWE generationWhat's needed to create "1 medical team" as a mindsetWhat the future holds for HEORThe views expressed here are mine and Riad's, and don’t reflect t...

Amber Spierer is the VP of Patient Affairs at EQRx, formally head of US Patient Engagement at Novartis. We talk about: Defining the patient journeyWhy understanding this journey is important strategicallyThe difference between viewing someone as a patient and as a personCurrent patient expectations around working with pharmaTacticsThe views expressed here are mine and Amber’s, and don’t reflect those of our employers. Pharma Sessions is hosted by Jonathan Kaskey Follow along on ...

I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics. We talk about: Transitioning from clinical practice to med affairsChanges in how other groups in pharma see med affairsThe differences between access and adoption (and how to impact both)Advances in patient engagement and much moreA quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers. At one point I reference the MAPS, Future of Medical Affairs report. You ...

Danie du Plessis is the EVP of Medical Affairs for Kyowa Kirin, a board member at the Medical Affairs Professional Society, and was previously the SVP of Global Medical Affairs for GSK. We talk about: Why Danie switched from primary care to working with pharmaIf a business background is important in med affairs leadershipLeading big organizations vs small organizationsHow important an understanding of the patient journey is to everything med affairsPharma Sessions is hosted by Jo...